Annual Net Income
-$5.57 M
+$4.64 M+45.43%
31 December 2023
Summary:
Titan Pharmaceuticals annual net profit is currently -$5.57 million, with the most recent change of +$4.64 million (+45.43%) on 31 December 2023. During the last 3 years, it has risen by +$12.67 million (+69.47%). TTNP annual net income is now -157.35% below its all-time high of $9.71 million, reached on 31 December 2013.TTNP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$2.09 M
-$1.03 M-97.45%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly net profit is currently -$2.09 million, with the most recent change of -$1.03 million (-97.45%) on 30 June 2024. Over the past year, it has dropped by -$1.75 million (-519.23%). TTNP quarterly net income is now -115.62% below its all-time high of $13.40 million, reached on 31 December 1997.TTNP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$5.46 M
-$507.00 K-10.23%
30 June 2024
Summary:
Titan Pharmaceuticals TTM net profit is currently -$5.46 million, with the most recent change of -$507.00 thousand (-10.23%) on 30 June 2024. Over the past year, it has increased by +$704.00 thousand (+11.42%). TTNP TTM net income is now -147.90% below its all-time high of $11.40 million, reached on 31 March 1998.TTNP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.4% | -519.2% | +11.4% |
| 3 y3 years | +69.5% | -9.3% | +41.4% |
| 5 y5 years | +38.3% | +25.3% | +65.9% |
TTNP Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.5% | -519.2% | +20.7% | -10.2% | +46.5% |
| 5 y | 5 years | at high | +69.5% | -519.2% | +62.5% | -10.2% | +71.4% |
| alltime | all time | -157.3% | +81.4% | -115.6% | +84.1% | -147.9% | +81.7% |
Titan Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.09 M(+97.5%) | -$5.46 M(+10.2%) |
| Mar 2024 | - | -$1.06 M(-46.2%) | -$4.95 M(-11.0%) |
| Dec 2023 | -$5.57 M(-45.4%) | -$1.97 M(+482.8%) | -$5.57 M(-9.7%) |
| Sept 2023 | - | -$338.00 K(-78.7%) | -$6.17 M(-27.2%) |
| June 2023 | - | -$1.59 M(-5.3%) | -$8.46 M(-9.4%) |
| Mar 2023 | - | -$1.68 M(-34.7%) | -$9.34 M(-8.5%) |
| Dec 2022 | -$10.21 M(+16.3%) | -$2.57 M(-2.7%) | -$10.21 M(+0.3%) |
| Sept 2022 | - | -$2.64 M(+7.1%) | -$10.18 M(+7.6%) |
| June 2022 | - | -$2.46 M(-3.1%) | -$9.46 M(+9.0%) |
| Mar 2022 | - | -$2.54 M(0.0%) | -$8.68 M(-1.2%) |
| Dec 2021 | -$8.78 M(-51.9%) | -$2.54 M(+32.6%) | -$8.78 M(-5.8%) |
| Sept 2021 | - | -$1.92 M(+14.0%) | -$9.32 M(-24.5%) |
| June 2021 | - | -$1.68 M(-36.4%) | -$12.34 M(-19.4%) |
| Mar 2021 | - | -$2.64 M(-14.4%) | -$15.30 M(-16.1%) |
| Dec 2020 | -$18.24 M(+10.8%) | -$3.08 M(-37.4%) | -$18.24 M(-4.5%) |
| Sept 2020 | - | -$4.93 M(+6.3%) | -$19.10 M(+12.5%) |
| June 2020 | - | -$4.64 M(-16.9%) | -$16.97 M(-3.2%) |
| Mar 2020 | - | -$5.58 M(+41.7%) | -$17.52 M(+6.5%) |
| Dec 2019 | -$16.46 M(+82.4%) | -$3.94 M(+40.6%) | -$16.46 M(+2.7%) |
| Sept 2019 | - | -$2.80 M(-46.1%) | -$16.02 M(+5.0%) |
| June 2019 | - | -$5.20 M(+15.1%) | -$15.26 M(+39.6%) |
| Mar 2019 | - | -$4.52 M(+28.9%) | -$10.94 M(+21.2%) |
| Dec 2018 | -$9.02 M(-36.9%) | -$3.50 M(+71.3%) | -$9.02 M(-1.7%) |
| Sept 2018 | - | -$2.04 M(+135.3%) | -$9.18 M(-18.9%) |
| June 2018 | - | -$869.00 K(-66.6%) | -$11.32 M(-18.6%) |
| Mar 2018 | - | -$2.60 M(-28.8%) | -$13.91 M(-2.8%) |
| Dec 2017 | -$14.31 M(-378.6%) | -$3.66 M(-12.7%) | -$14.31 M(+10.3%) |
| Sept 2017 | - | -$4.19 M(+21.4%) | -$12.97 M(+13.8%) |
| June 2017 | - | -$3.45 M(+14.8%) | -$11.40 M(-386.8%) |
| Mar 2017 | - | -$3.00 M(+29.1%) | $3.98 M(-22.6%) |
| Dec 2016 | $5.13 M(-145.5%) | -$2.33 M(-11.2%) | $5.13 M(-0.6%) |
| Sept 2016 | - | -$2.62 M(-122.0%) | $5.17 M(-13.6%) |
| June 2016 | - | $11.93 M(-746.2%) | $5.98 M(-172.7%) |
| Mar 2016 | - | -$1.85 M(-19.5%) | -$8.23 M(-27.1%) |
| Dec 2015 | -$11.28 M(+369.4%) | -$2.29 M(+27.0%) | -$11.28 M(+19.3%) |
| Sept 2015 | - | -$1.81 M(-20.8%) | -$9.46 M(+36.4%) |
| June 2015 | - | -$2.28 M(-53.4%) | -$6.93 M(+26.2%) |
| Mar 2015 | - | -$4.90 M(+935.3%) | -$5.50 M(+128.7%) |
| Dec 2014 | -$2.40 M(-124.7%) | -$473.00 K(-166.1%) | -$2.40 M(+12.3%) |
| Sept 2014 | - | $716.00 K(-185.0%) | -$2.14 M(-46.5%) |
| June 2014 | - | -$842.00 K(-53.3%) | -$4.00 M(-309.9%) |
| Mar 2014 | - | -$1.80 M(+763.2%) | $1.91 M(-80.4%) |
| Dec 2013 | $9.71 M(-164.0%) | -$209.00 K(-81.7%) | $9.71 M(+0.7%) |
| Sept 2013 | - | -$1.15 M(-122.6%) | $9.64 M(+247.7%) |
| June 2013 | - | $5.06 M(-15.6%) | $2.77 M(-169.1%) |
| Mar 2013 | - | $6.00 M(-2250.9%) | -$4.01 M(-73.5%) |
| Dec 2012 | -$15.18 M(-0.2%) | -$279.00 K(-96.5%) | -$15.18 M(-14.7%) |
| Sept 2012 | - | -$8.01 M(+364.8%) | -$17.80 M(+68.1%) |
| June 2012 | - | -$1.72 M(-66.6%) | -$10.59 M(-33.2%) |
| Mar 2012 | - | -$5.16 M(+78.2%) | -$15.85 M(+4.3%) |
| Dec 2011 | -$15.20 M(+122.5%) | -$2.90 M(+260.4%) | -$15.20 M(-8.4%) |
| Sept 2011 | - | -$804.00 K(-88.5%) | -$16.60 M(+2.6%) |
| June 2011 | - | -$6.99 M(+54.9%) | -$16.18 M(+46.6%) |
| Mar 2011 | - | -$4.51 M(+5.0%) | -$11.04 M(+61.6%) |
| Dec 2010 | -$6.83 M(+16.1%) | -$4.30 M(+1019.5%) | -$6.83 M(+70.7%) |
| Sept 2010 | - | -$384.00 K(-79.2%) | -$4.00 M(-23.2%) |
| June 2010 | - | -$1.85 M(+505.2%) | -$5.21 M(+2.2%) |
| Mar 2010 | - | -$305.00 K(-79.2%) | -$5.10 M(-13.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$5.89 M(-66.6%) | -$1.47 M(-7.8%) | -$5.89 M(+33.2%) |
| Sept 2009 | - | -$1.59 M(-8.2%) | -$4.42 M(-49.4%) |
| June 2009 | - | -$1.74 M(+59.2%) | -$8.72 M(-40.5%) |
| Mar 2009 | - | -$1.09 M(-81.5%) | -$14.67 M(-42.5%) |
| Sept 2008 | - | -$5.90 M(-23.2%) | -$25.52 M(+6.6%) |
| June 2008 | - | -$7.68 M(+34.2%) | -$23.95 M(+21.0%) |
| Mar 2008 | - | -$5.72 M(-7.9%) | -$19.80 M(+12.2%) |
| Dec 2007 | -$17.65 M(+12.1%) | -$6.22 M(+43.8%) | -$17.65 M(+20.1%) |
| Sept 2007 | - | -$4.32 M(+22.4%) | -$14.70 M(-0.1%) |
| June 2007 | - | -$3.53 M(-1.1%) | -$14.71 M(+0.7%) |
| Mar 2007 | - | -$3.57 M(+9.4%) | -$14.61 M(-7.2%) |
| Dec 2006 | -$15.74 M(-29.9%) | -$3.27 M(-24.7%) | -$15.74 M(-4.7%) |
| Sept 2006 | - | -$4.34 M(+26.7%) | -$16.52 M(-11.0%) |
| June 2006 | - | -$3.43 M(-27.2%) | -$18.56 M(-11.1%) |
| Mar 2006 | - | -$4.71 M(+16.3%) | -$20.87 M(-7.1%) |
| Dec 2005 | -$22.46 M(-13.6%) | -$4.05 M(-36.5%) | -$22.46 M(-14.3%) |
| Sept 2005 | - | -$6.38 M(+11.1%) | -$26.21 M(+0.4%) |
| June 2005 | - | -$5.74 M(-8.8%) | -$26.11 M(+0.7%) |
| Mar 2005 | - | -$6.30 M(-19.3%) | -$25.92 M(-0.3%) |
| Dec 2004 | -$26.00 M(-13.0%) | -$7.80 M(+24.4%) | -$26.00 M(-9.4%) |
| Sept 2004 | - | -$6.27 M(+12.9%) | -$28.71 M(+0.4%) |
| June 2004 | - | -$5.55 M(-12.9%) | -$28.61 M(-3.8%) |
| Mar 2004 | - | -$6.38 M(-39.3%) | -$29.74 M(-0.5%) |
| Dec 2003 | -$29.89 M(+6.1%) | -$10.51 M(+70.4%) | -$29.89 M(+5.7%) |
| Sept 2003 | - | -$6.17 M(-7.7%) | -$28.28 M(-3.8%) |
| June 2003 | - | -$6.68 M(+2.3%) | -$29.41 M(-1.2%) |
| Mar 2003 | - | -$6.53 M(-26.7%) | -$29.76 M(+5.6%) |
| Dec 2002 | -$28.18 M(+61.4%) | -$8.90 M(+22.0%) | -$28.18 M(+10.1%) |
| Sept 2002 | - | -$7.30 M(+3.8%) | -$25.60 M(+10.9%) |
| June 2002 | - | -$7.03 M(+42.1%) | -$23.09 M(+29.0%) |
| Mar 2002 | - | -$4.95 M(-21.7%) | -$17.89 M(+2.5%) |
| Dec 2001 | -$17.46 M(-7.0%) | -$6.32 M(+32.1%) | -$17.46 M(+15.3%) |
| Sept 2001 | - | -$4.79 M(+161.0%) | -$15.15 M(-20.6%) |
| June 2001 | - | -$1.83 M(-59.4%) | -$19.07 M(-3.0%) |
| Mar 2001 | - | -$4.52 M(+12.8%) | -$19.66 M(+4.6%) |
| Dec 2000 | -$18.79 M(+66.3%) | -$4.01 M(-54.0%) | -$18.79 M(+6.3%) |
| Sept 2000 | - | -$8.71 M(+259.5%) | -$17.68 M(+55.5%) |
| June 2000 | - | -$2.42 M(-33.6%) | -$11.37 M(-5.6%) |
| Mar 2000 | - | -$3.65 M(+25.8%) | -$12.05 M(+7.6%) |
| Dec 1999 | -$11.30 M(+6.6%) | -$2.90 M(+20.8%) | -$11.20 M(-2.6%) |
| Sept 1999 | - | -$2.40 M(-22.6%) | -$11.50 M(-3.4%) |
| June 1999 | - | -$3.10 M(+10.7%) | -$11.90 M(+8.2%) |
| Mar 1999 | - | -$2.80 M(-12.5%) | -$11.00 M(+3.8%) |
| Dec 1998 | -$10.60 M(-1866.7%) | -$3.20 M(+14.3%) | -$10.60 M(-276.7%) |
| Sept 1998 | - | -$2.80 M(+27.3%) | $6.00 M(+20.0%) |
| June 1998 | - | -$2.20 M(-8.3%) | $5.00 M(-56.1%) |
| Mar 1998 | - | -$2.40 M(-117.9%) | $11.40 M(+1800.0%) |
| Dec 1997 | $600.00 K(-104.7%) | $13.40 M(-452.6%) | $600.00 K(-103.6%) |
| Sept 1997 | - | -$3.80 M(-190.5%) | -$16.80 M(+6.3%) |
| June 1997 | - | $4.20 M(-131.8%) | -$15.80 M(-30.4%) |
| Mar 1997 | - | -$13.20 M(+230.0%) | -$22.70 M(+76.0%) |
| Dec 1996 | -$12.90 M(+10.3%) | -$4.00 M(+42.9%) | -$12.90 M(+8.4%) |
| Sept 1996 | - | -$2.80 M(+3.7%) | -$11.90 M(-0.8%) |
| June 1996 | - | -$2.70 M(-20.6%) | -$12.00 M(-1.6%) |
| Mar 1996 | - | -$3.40 M(+13.3%) | -$12.20 M(+4.3%) |
| Dec 1995 | -$11.70 M | -$3.00 M(+3.4%) | -$11.70 M(+34.5%) |
| Sept 1995 | - | -$2.90 M(0.0%) | -$8.70 M(+50.0%) |
| June 1995 | - | -$2.90 M(0.0%) | -$5.80 M(+100.0%) |
| Mar 1995 | - | -$2.90 M | -$2.90 M |
FAQ
- What is Titan Pharmaceuticals annual net profit?
- What is the all time high annual net income for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual net income year-on-year change?
- What is Titan Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly net income year-on-year change?
- What is Titan Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals TTM net income year-on-year change?
What is Titan Pharmaceuticals annual net profit?
The current annual net income of TTNP is -$5.57 M
What is the all time high annual net income for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual net profit is $9.71 M
What is Titan Pharmaceuticals annual net income year-on-year change?
Over the past year, TTNP annual net profit has changed by +$4.64 M (+45.43%)
What is Titan Pharmaceuticals quarterly net profit?
The current quarterly net income of TTNP is -$2.09 M
What is the all time high quarterly net income for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly net profit is $13.40 M
What is Titan Pharmaceuticals quarterly net income year-on-year change?
Over the past year, TTNP quarterly net profit has changed by -$1.75 M (-519.23%)
What is Titan Pharmaceuticals TTM net profit?
The current TTM net income of TTNP is -$5.46 M
What is the all time high TTM net income for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high TTM net profit is $11.40 M
What is Titan Pharmaceuticals TTM net income year-on-year change?
Over the past year, TTNP TTM net profit has changed by +$704.00 K (+11.42%)